| For: | Leelawat K, Narong S, Wannaprasert J, Ratanashu-ek T. Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma. World J Gastroenterol 2010; 16(37): 4697-4703 [PMID: 20872971 DOI: 10.3748/wjg.v16.i37.4697] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i37/4697.htm |
| Number | Citing Articles |
| 1 |
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2) doi: 10.1016/j.suronc.2016.12.009
|
| 2 |
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2021; doi: 10.1007/978-3-030-37482-2_15-1
|
| 3 |
Tatsuki Mizuochi, Ken-ichiro Konishi. Introduction to Biliary Atresia. 2021; doi: 10.1007/978-981-16-2160-4_17
|
| 4 |
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022; 14(6) doi: 10.3390/cancers14061493
|
| 5 |
Hiroaki Haga, Tushar Patel. Molecular diagnosis of intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2) doi: 10.1002/jhbp.156
|
| 6 |
Hong Jin Yoon, Sung Ill Jang, Dong Ki Lee. Advanced ERCP for Complicated and Refractory Biliary and Pancreatic Diseases. 2020; doi: 10.1007/978-981-13-0608-2_9
|
| 7 |
PHANTHAKARN TIT-OON, DARANEE CHOKCHAICHAMNANKIT, AMNART KHONGMANEE, PHANEE SAWANGAREETRAKUL, JISNUSON SVASTI, CHANTRAGAN SRISOMSAP. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture. International Journal of Oncology 2014; 45(5) doi: 10.3892/ijo.2014.2636
|
| 8 |
Ravinnipa Chanakankun, Tanakorn Proungvitaya, Daraporn Chua‑On, Temduang Limpaiboon, Sittiruk Roytrakul, Apinya Jusakul, Attapol Titapun, Apiwat Jarearnrat, Siriporn Proungvitaya. Serum coiled‑coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.11162
|
| 9 |
Chatmanee Lertudomphonwanit, Reena Mourya, Lin Fei, Yue Zhang, Sridevi Gutta, Li Yang, Kevin E. Bove, Pranavkumar Shivakumar, Jorge A. Bezerra. Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia. Science Translational Medicine 2017; 9(417) doi: 10.1126/scitranslmed.aan8462
|
| 10 |
Sven H. Loosen, Mihael Vucur, Christian Trautwein, Christoph Roderburg, Tom Luedde. Circulating Biomarkers for Cholangiocarcinoma. Digestive Diseases 2018; 36(4) doi: 10.1159/000488342
|
| 11 |
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2022; doi: 10.1007/978-3-030-41683-6_15
|
| 12 |
Naoshi Nishida. Biomarkers and Management of Cholangiocarcinoma: Unveiling New Horizons for Precision Therapy. Cancers 2025; 17(7) doi: 10.3390/cancers17071243
|
| 13 |
Sven A. Lang, Jan Bednarsch, Katharina Joechle, Iakovos Amygdalos, Zoltan Czigany, Lara Heij, Tom F. Ulmer, Ulf P. Neumann. Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art. Expert Review of Gastroenterology & Hepatology 2021; 15(5) doi: 10.1080/17474124.2021.1912591
|
| 14 |
Si-Young Kim, Hee-Seung Lee, Seung-Min Bang, Dai-Hoon Han, Ho-Kyoung Hwang, Gi-Hong Choi, Moon-Jae Chung, Seung-Up Kim. Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma. Cancers 2021; 13(8) doi: 10.3390/cancers13081828
|
| 15 |
Peter Findeisen, Michael Neumaier. Functional protease profiling for diagnosis of malignant disease. PROTEOMICS – Clinical Applications 2012; 6(1-2) doi: 10.1002/prca.201100058
|
| 16 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; doi: 10.1002/9781119756422.ch17
|
| 17 |
Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver International 2019; 39(S1) doi: 10.1111/liv.14090
|
| 18 |
A. Singh, A. Gelrud, B. Agarwal. Biliary strictures: diagnostic considerations and approach. Gastroenterology Report 2015; 3(1) doi: 10.1093/gastro/gou072
|
| 19 |
Richard Tang, Nicholas Latchana, Amir A. Rahnemai-Azar, Timothy M. Pawlik. Primary and Metastatic Liver Tumors. 2018; doi: 10.1007/978-3-319-91977-5_8
|
| 20 |
ELISA PAOLICCHI, PAOLA PACETTI, ELISA GIOVANNETTI, ANDREA MAMBRINI, MASSIMO ORLANDI, FRANCESCO CREA, ANTONELLO A. ROMANI, ROBERTA TARTARINI, ROMANO DANESI, GODEFRIDUS J. PETERS, MAURIZIO CANTORE. A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma. Oncology Letters 2013; 6(5) doi: 10.3892/ol.2013.1559
|
| 21 |
Majda Haznadar, Christopher M. Diehl, Amelia L. Parker, Kristopher W. Krausz, Elise D. Bowman, Siritida Rabibhadana, Marshonna Forgues, Vajarabhongsa Bhudhisawasdi, Frank J. Gonzalez, Chulabhorn Mahidol, Anuradha Budhu, Xin W. Wang, Mathuros Ruchirawat, Curtis C. Harris. Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma. Cancer Epidemiology, Biomarkers & Prevention 2019; 28(10) doi: 10.1158/1055-9965.EPI-19-0453
|
| 22 |
E. Gigante, V. Untereiner, S. Caruso, R. Rhaiem, L. Grados, C. Boulagnon‐Rombi, S. Adam, G. D. Sockalingum, R. Garnotel, G. Thiefin. Diagnostic and Prognostic Values of Bile Biomarkers for Malignant Biliary Stenosis. Liver International 2026; 46(5) doi: 10.1111/liv.70637
|
| 23 |
XIAOJUN ZENG, HUALIN TAO. Diagnostic and prognostic serum marker of cholangiocarcinoma (Review). Oncology Letters 2015; 9(1) doi: 10.3892/ol.2014.2696
|
| 24 |
A. Marichez, G.T. Passand, M. Boubaddi, N. Toussaint, B. Fernandez, C. Laurent, A.A. Raymond, F. Saltel, L. Chiche. Extra-hepatic cholangiocarcinoma diagnosis: from classical pathological analysis to the emerging omics tests. European Journal of Surgical Oncology 2026; 52(5) doi: 10.1016/j.ejso.2026.111770
|
| 25 |
Barbara Maria Piskór, Andrzej Przylipiak, Emilia Dąbrowska, Iwona Sidorkiewicz, Marek Niczyporuk, Maciej Szmitkowski, Sławomir Ławicki. Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer. Journal of Clinical Medicine 2021; 10(7) doi: 10.3390/jcm10071436
|
| 26 |
Wei Cheng, Yunlong Chen, Feng Yan, Lin Ding, Shijia Ding, Huangxian Ju, Yibing Yin. Ultrasensitive scanometric strategy for detection of matrix metalloproteinases using a histidine tagged peptide–Au nanoparticle probe. Chemical Communications 2011; 47(10) doi: 10.1039/c0cc04441e
|
| 27 |
Chencheng Xie, Khalil Aloreidi, Bhavesh Patel, Timothy Ridgway, Thavam Thambi-Pillai, Gary Timmerman, Adeel Khan, Muslim Atiq. Indeterminate biliary strictures: a simplified approach. Expert Review of Gastroenterology & Hepatology 2018; 12(2) doi: 10.1080/17474124.2018.1391090
|
| 28 |
Bin Wang, Liang Chen, Hao-Teng Chang. Potential Diagnostic and Prognostic Biomarkers for Cholangiocarcinoma in Serum and Bile. Biomarkers in Medicine 2016; 10(6) doi: 10.2217/bmm-2015-0062
|
| 29 |
Xiang-de Shi, Xian-huan Yu, Wen-rui Wu, Xiao-lin Xu, Jie-Yu Wang, Lei-bo Xu, Rui Zhang, Chao Liu. Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma. Oncotarget 2016; 7(43) doi: 10.18632/oncotarget.11859
|
| 30 |
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2012; 9(1) doi: 10.1038/nrgastro.2011.222
|
| 31 |
Christopher L. Bowlus, Kristin A. Olson, M. Eric Gershwin. Evaluation of indeterminate biliary strictures. Nature Reviews Gastroenterology & Hepatology 2016; 13(1) doi: 10.1038/nrgastro.2015.182
|
| 32 |
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile. Current Topics in Medicinal Chemistry 2024; 24(8) doi: 10.2174/0115680266290367240130054142
|
| 33 |
Alan Brijbassie, Paul Yeaton. Approach to the patient with a biliary stricture. Techniques in Gastrointestinal Endoscopy 2016; 18(2) doi: 10.1016/j.tgie.2016.05.001
|
| 34 |
Lavinia-Patricia Mocan, Maria Ilieș, Carmen Stanca Melincovici, Mihaela Spârchez, Rareș Crăciun, Iuliana Nenu, Adelina Horhat, Cristian Tefas, Zeno Spârchez, Cristina Adela Iuga, Tudor Mocan, Carmen Mihaela Mihu. Novel approaches in search for biomarkers of cholangiocarcinoma. World Journal of Gastroenterology 2022; 28(15): 1508-1525 doi: 10.3748/wjg.v28.i15.1508
|
| 35 |
Yuan Shi, Xiaxing Deng, Qian Zhan, Baiyong Shen, Xiaolong Jin, Zhecheng Zhu, Hao Chen, Hongwei Li, Chenghong Peng. A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2013; 17(9) doi: 10.1007/s11605-013-2182-9
|
| 36 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9) doi: 10.1038/s41575-020-0310-z
|
| 37 |
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6) doi: 10.3109/1354750X.2014.923048
|
| 38 |
Atsushi Matsuda, Atsushi Kuno, Hideki Matsuzaki, Toru Kawamoto, Toshihide Shikanai, Yasuni Nakanuma, Masakazu Yamamoto, Nobuhiro Ohkohchi, Yuzuru Ikehara, Junichi Shoda, Jun Hirabayashi, Hisashi Narimatsu. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. Journal of Proteomics 2013; 85 doi: 10.1016/j.jprot.2013.04.017
|
| 39 |
Teijiro Hirashita, Yukio Iwashita, Masayuki Ohta, Yoko Komori, Hidetoshi Eguchi, Kazuhiro Yada, Seigo Kitano. Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2012; 16(4) doi: 10.1007/s11605-011-1813-2
|
| 40 |
Arezou Abbasi, Amir A. Rahnemai-Azar, Sean M. Ronnekleiv-Kelly, Daniel E. Abbott, Sharon M. Weber. Intrahepatic Cholangiocarcinoma. 2019; doi: 10.1007/978-3-030-22258-1_2
|
| 41 |
Pedro M. Rodrigues, Arndt Vogel, Marco Arrese, Domingo C. Balderramo, Juan W. Valle, Jesus M. Banales. Next-Generation Biomarkers for Cholangiocarcinoma. Cancers 2021; 13(13) doi: 10.3390/cancers13133222
|
| 42 |
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bohyun Kim, Seong-Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji Hae Nahm, Won Suk Park, Eunkyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoungbun Lee, Dong Ho Lee, Myung Ah Lee, Seung Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Yong Eun Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon Seong Park. Practice guidelines for managing extrahepatic biliary tract cancers. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2) doi: 10.14701/ahbps.23-170
|
| 43 |
Natalia Calanzani, Paige E. Druce, Claudia Snudden, Kristi M. Milley, Rachel Boscott, Dawnya Behiyat, Smiji Saji, Javiera Martinez-Gutierrez, Jasmeen Oberoi, Garth Funston, Mike Messenger, Jon Emery, Fiona M. Walter. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Advances in Therapy 2021; 38(2) doi: 10.1007/s12325-020-01571-z
|
| 44 |
Charilaos Papafragkakis, Jeffrey Lee. Comprehensive management of cholangiocarcinoma: Part I. Diagnosis. International Journal of Gastrointestinal Intervention 2017; 6(2) doi: 10.18528/gii1500341
|
| 45 |
Sang-Hoon Lee, Si Young Song. Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications. Cancers 2024; 16(9) doi: 10.3390/cancers16091761
|
| 46 |
Mustafa Gunes, Ahu Serap Kemik, Necip Pirincci, Ilhan Gecit, Kerem Taken, Mehmet Bilgehan Yuksel, Mehmet Kaba, Recep Eryilmaz. Preoperative Levels of Matrix Metalloproteinase-7 and -9 and Tissue Inhibitor of Matrix Metalloproteinase-1 Relation to Pathologic Parameters in Bladder Carcinoma Patients. Asian Pacific Journal of Cancer Prevention 2013; 14(2) doi: 10.7314/APJCP.2013.14.2.873
|
| 47 |
Rocio I.R. Macias, Hiroaki Kanzaki, Carmen Berasain, Matias A. Avila, Jose J.G. Marin, Yujin Hoshida. The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic Significance. The American Journal of Pathology 2025; 195(3) doi: 10.1016/j.ajpath.2024.06.013
|
| 48 |
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki Takahashi. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2. International Journal of Clinical Oncology 2024; 29(5) doi: 10.1007/s10147-024-02497-0
|
| 49 |
Sam C. Wang, Justin R. Parekh, Matthew R. Porembka, Hari Nathan, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, T. Peter Kingham, William R. Jarnagin, Peter J. Allen. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients. Journal of Gastrointestinal Surgery 2016; 20(5) doi: 10.1007/s11605-015-3057-z
|
| 50 |
Bo Tang, Jian Du, Yang Li, Fang Tang, Zhenran Wang, Songqing He. EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0271-6
|